Complete Blood Count Findings in Megaloblastic Anemia Due to Vitamin B12 Deficiency
In a patient with megaloblastic anemia from vitamin B12 deficiency, the complete blood count will show macrocytic anemia (hemoglobin typically <12 g/dL in women, <13 g/dL in men) with an elevated mean corpuscular volume (MCV >98–100 fL, often >110 fL in severe cases), and the peripheral smear will reveal hypersegmented neutrophils—the hallmark morphologic feature of megaloblastic change. 1, 2, 3
Hematologic Parameters
Red Blood Cell Indices
Hemoglobin levels are reduced, with severe deficiency often presenting with hemoglobin <8 g/dL; in one cohort, 69% of patients with megaloblastic anemia had severe anemia with mean hemoglobin of 6.8 g/dL. 4, 3
Mean corpuscular volume (MCV) is characteristically elevated, typically >98 fL and frequently >104–110 fL in established deficiency; patients with MCV >110 fL are significantly more likely to have megaloblastic anemia (p=0.0007). 1, 5, 3
Macrocytosis precedes anemia in the natural history of B12 deficiency, with elevated MCV often being the earliest laboratory abnormality before hemoglobin drops. 1
Reticulocyte Count
Reticulocyte count is characteristically low or inappropriately normal for the degree of anemia, reflecting ineffective erythropoiesis and reduced red cell production—a key feature distinguishing megaloblastic from hemolytic causes of macrocytosis. 2, 6
A low reticulocyte index signals impaired bone marrow production and helps differentiate B12 deficiency from hemolytic anemia or acute hemorrhage, which would show elevated reticulocytes. 2
Red Cell Distribution Width (RDW)
- RDW may be elevated, particularly when iron deficiency coexists with B12 deficiency; an elevated RDW can unmask concurrent iron deficiency even when the MCV appears elevated, as microcytosis and macrocytosis can neutralize each other. 2, 6
Peripheral Blood Smear Findings
Morphologic Hallmarks
Hypersegmented neutrophils (neutrophils with ≥6 nuclear lobes) are the pathognomonic finding of megaloblastic anemia and reflect impaired DNA synthesis affecting all hematopoietic lineages. 1, 2
Macro-ovalocytes (large, oval-shaped red blood cells) are characteristic of megaloblastic change. 1
Anisocytosis and poikilocytosis (variation in red cell size and shape) are commonly present. 1
White Blood Cell and Platelet Findings
Pancytopenia may occur in severe cases, with leukopenia and/or thrombocytopenia accompanying the anemia; the presence of multilineage cytopenias should raise suspicion for myelodysplastic syndrome if B12 deficiency is excluded. 7, 2
Hypersegmented neutrophils affect the granulocytic lineage and are present in 10% or more of peripheral blood cells in established megaloblastic anemia. 7
Important Clinical Caveats
Masked Macrocytosis
Macrocytosis can be masked when B12 deficiency coexists with conditions causing microcytosis (iron deficiency, thalassemia trait, chronic inflammation); in these cases, the MCV may be normal or even low despite underlying megaloblastic change. 8, 2
When iron deficiency and B12 deficiency coexist, the elevated RDW becomes a critical clue, indicating mixed deficiency even when MCV is normal. 2, 6
In inflammatory conditions, ferritin up to 100 μg/L may still indicate iron deficiency despite appearing normal, and transferrin saturation <20% is a more reliable marker. 2, 6
Bone Marrow Findings (When Performed)
Bone marrow examination shows hypercellular marrow with megaloblastic changes in all three cell lines (erythroid, granulocytic, megakaryocytic), with dysplastic features in ≥10% of cells. 7
Giant metamyelocytes and band forms are characteristic findings in the granulocytic series. 7
Bone marrow is typically not required for diagnosis when serum B12 is <180 pg/mL (<133 pmol/L) and clinical/hematologic features are consistent, but should be considered if cytopenias persist after B12 replacement or if myelodysplastic syndrome is suspected. 1, 2
Diagnostic Thresholds
Serum B12 <180 pg/mL (<133 pmol/L) confirms deficiency and requires immediate treatment without additional testing. 1, 2
For indeterminate B12 levels (180–350 pg/mL), measure methylmalonic acid (MMA); MMA >271 nmol/L confirms functional B12 deficiency. 1, 2
One-third of patients with B12 deficiency may not have macrocytic anemia at presentation, particularly early in the disease course or when concurrent iron deficiency is present, making serum B12 and MMA testing essential when clinical suspicion is high. 1